Cargando…
Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma
Glioblastomas, accounting for approximately 50% of gliomas, comprise the most aggressive, highly heterogeneous, and malignant brain tumors. The objective of this study was to develop and evaluate a new targeted therapy, i.e., highly potent natural compound verrucarin A (Ver-A), delivered with monocl...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773723/ https://www.ncbi.nlm.nih.gov/pubmed/35052809 http://dx.doi.org/10.3390/biomedicines10010130 |